"This volume presents manuscripts stemming from the conference "Sixth International Cancer Vaccine Symposium: Stages of Cancer Vaccine Development," held at the New York Academy of Sciences Conference Center on Oct. 28-30, 2008."--P. v.
Some scientific and organizational challenges in cancer immunology
The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells
Brain tumor immunotherapy with type-1 polarizing strategies
Harnessing human dendritic cell subsets to design novel vaccines
Dendritic cell-based vaccines for pancreatic cancer and melanoma
Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers
Witch hunt against tumor cells enhanced by dendritic cells
Harnessing CD1D-restricted t cells toward antitumor immunity in humans
Immunity against cyclin B1 tumor antigen delays development of spontaneous cyclin B1-positive tumors in p53-/- mice
Targets of protective tumor immunity
Identification of immunologic biomarkers associated with clinical response after immune-based therapy for cancer
Harnessing dendritic cells to generate cancer vaccines
Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells
Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model
Hematopoietic stem and progenitor cells and the inflammatory response.
OBNB doesn't sell books, but you may be able to find a copy at one of these websites:
Cancer vaccines : sixth international symposium. ISBN 9781573317597. Published by Blackwell Publishing on behalf of the New York Academy of Sciences in 2009. Publication and catalogue information, links to buy online and reader comments.
